Here's the mechanism that creates prions, the 'bad' proteins
At the molecular level, the difference between Doctor Jekyll and Mr Hyde lies in a metal, copper. In its physiological form, the prion protein (PrPC ) is 'good' and is involved in normal body processes. It can happen, however, that because of some as yet unknown mechanism, it changes form and turns into a threat for the health of humans and animals (it is responsible for neurodegenerative diseases such as spongiform encephalopathies).
According to a new SISSA study, the mechanism underlying this change is a metal, copper, or rather a particular region of the protein to which the metal binds, which acts as a sort of 'switch' that turns PrPC into its terrible alter ego.
"We still don't know what complex molecular mechanisms cause the prion protein to become bad," explains Giuseppe Legname, professor at the International School for Advanced Studies (SISSA) in Trieste who coordinated the new study, "nor do we know any treatments to cure prion diseases. Our research has finally uncovered a critical cofactor, which is capable of triggering the transformation of prions proteins from good to bad. And this cofactor is copper which binds to an amino acid sequence of the prion protein, known as 'fifth copper binding site', which has so far been poorly studied".
"In physiological conditions, copper is tightly bound to two histidine amino acids", continues Legname. "When copper is bound in this way it seems to protect the prion protein. When instead copper is missing or is bound to one rather than two histidines, that's when problems arise: the prion protein becomes unstable and turns into a bad and infectious prion".
To reach this conclusion, the researchers used multidisciplinary experimental approaches, ranging from structural to cellular biology. "It all started with an intuition we published in the journal Biochemistry in 2012", explains Gabriele Giachin, first author of the study and former SISSA PhD student (today at the European Synchrotron Radiation Facility, ESRF, in Grenoble, France).
"On that occasion, we hypothesized that the pathological genetic mutations present in the prion protein could affect copper coordination". Starting from this intuition, Giachin and colleagues went on to conduct in-depth experiments using XAFS (X-ray absorption fine structure) spectroscopy, exploiting the powerful X-rays available at the Grenoble synchrotron. Then, drawing on the consolidated expertise in molecular and cellular biology available at the SISSA Laboratory of Prion Biology coordinated by Legname, the group confirmed the hypothesis in living cell systems.
"These results finally answer a fundamental question: what mechanism underlies the appearance of prions?", concludes Legname. "We have been the first to provide a detailed description of the role of copper in prion conversion, opening the way for the development of new drugs targeting this copper binding site, and thus for new potential treatments".
The study was conducted through the collaboration of a group of SISSA scientists (in addition to Giachin and Legname, the group includes Thao Mai, Thanh Hoa Tran, Giulia Salzano and Federico Benetti) and a group coordinated by the University of Rome "La Sapienza", led by Paola D'Angelo.
Prion proteins and prions Prions are proteins that have undergone a change in structure from a physiological "good" form normally present in our brain to an aberrant (or "bad") form capable of causing degeneration of nervous tissue and diseases, some of which very severe. Among the diseases are Creutzfeld Jakob disease in humans and "mad cow" disease in cattle. Unique in nature, prions can also be infectious, like viruses and bacteria, in that they can be transmitted between individuals of the same or even different species.
Federica Sgorbissa | EurekAlert!
A better way to measure the stiffness of cancer cells
01.03.2017 | Duke University
Humans have three times more brown body fat
01.03.2017 | Technische Universität München
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.
On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
01.03.2017 | Health and Medicine
01.03.2017 | Physics and Astronomy
01.03.2017 | Life Sciences